NIH-funded research U01 cooperative agreement

Understanding how impaired hypoglycemia awareness develops in type 1 diabetes and how automated insulin delivery and exercise might help restore it

Official title: Characterizing the evolution of impaired hypoglycemia awareness in people with type 1 diabetes and the impact of automated insulin delivery and exercise on restoring hypoglycemia awareness

Funded at University of Melbourne · NIH-11322740 · Data updated 2026-11-12

This study looks at adults with type 1 diabetes who struggle to sense hypoglycemia and tests whether automated insulin delivery and exercise can help restore their awareness.

More Diabetes research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Melbourne
NIH-funded
Lab location1 site (Melbourne, Australia)
Project startSeptember 25, 2022
Project endDecember 31, 2027
Funding year2026
Award (this year)$186,369
NIH project number5U01DK135122-04
Project IDNIH-11322740 on NIH RePORTER

Who could benefit from this research

Could help

Adults with type 1 diabetes who have impaired hypoglycemia awareness and are eligible for automated insulin delivery systems.

Less likely to help

People without impaired hypoglycemia awareness or those not using or eligible for automated insulin delivery may not benefit.

What this research studies

People with type 1 diabetes who have impaired hypoglycemia awareness may not notice warning symptoms and are at higher risk of severe hypoglycemia. The study will follow adults over time to understand how awareness changes and will test interventions that include automated insulin delivery systems and structured high-intensity exercise. Participants may take part in a randomized controlled trial to see if these approaches improve their ability to recognize low blood sugar and respond appropriately. The research could lead to better tools and strategies to prevent dangerous hypoglycemic events. The study is conducted at the University of Melbourne with clinical oversight and monitoring.

Why it matters

Potential benefit: If successful, the work could lead to safer diabetes management through improved recognition of low blood sugar and more effective use of automated insulin systems and exercise.

How similar studies have gone: Previous small studies with education or technology have shown signals of benefit, but larger, longer trials are needed.

Where this research is happening

  • University of Melbourne
    Melbourne, Australia
    Active

Researchers

  • Principal investigator: O'neal, David Norman — University of Melbourne
  • Study coordinator: O'neal, David Norman

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.